Page 116 - 南京医科大学学报自然科学版
P. 116
第42卷第10期
·1458 · 南 京 医 科 大 学 学 报 2022年10月
[9] 中华医学会肿瘤学分会,中华医学会杂志社,韩宝惠. [16] 顾嘉玺,陈建乐,倪布清,等. 外科微创房颤消融术后复
中华医学会肿瘤学分会肺癌临床诊疗指南(2021 版) 发的危险因素分析[J]. 中华胸心血管外科杂志,2020,
[J]. 中华医学杂志,2021,101(23):1725-1757 36(12):761-762
[10] HEIJMAN J,GUICHARD J,DOBREV D,et al. Transla⁃ [17] BALDWIN D R. Management of pulmonary nodules accord⁃
tional challenges in atrial fibrillation[J]. Circ Res,2018, ing to the 2015 British Thoracic Society guidelines. Key
122(5):752-773 messages for clinical practice[J]. Polskie Archiwum Me⁃
[11] 王乃迪,张海澄.《2020 ESC心房颤动诊断和管理指南》 dycyny Wewnetrznej,2016,126(4):262-274
更新要点解读[J]. 中国心血管病研究,2020,18(11): [18] ZHANG Y,SUN H,LI M,et al. Impact of stand ⁃ alone
966-973 minimally invasive radiofrequency ablation with left atrial
[12]CALKINS H,HINDRICKS G,CAPPATO R,et al. 2017 appendectomy on left atrial function assessed by echocar⁃
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus diography[J]. Quant Imaging Med Surg,2020,10(5):
statement on catheter and surgical ablation of atrial fibril⁃ 970-978
lation[J]. Heart Rhythm,2017,14(10):e275-e444 [19] 潘相龙,许 晶,何志成,等. 胸腔镜切口数对肺切除手
[13] 韩宝惠. 中华医学会肺癌临床诊疗指南(2019 版)[J]. 术早期疗效的影响[J]. 南京医科大学学报(自然科学
肿瘤研究与临床,2020,32(4):217-249 版),2021,41(6):889-891
[14] 陈 恺,刘 娜,陈胜家. 单操作孔胸腔镜肺叶切除术 [20] 张 伟,刘 鸿,邵永丰,等. 外科微创消融在房颤治疗
治疗Ⅰ期/Ⅱa 期非小细胞肺癌患者的回顾性分析[J]. 中的应用[J]. 南京医科大学学报(自然科学版),2020,
当代医学,2021,27(16):115-117 40(12):1804-1808
[15] 徐汉杰,陈桂荣,黄 俊,等. 单孔法与多孔法胸腔镜下 [21] 凌协安,万 军,彭 彬. 单孔全胸腔镜肺叶切除术的
肺叶切除术治疗非小细胞肺癌疗效的系统评价与Meta 应用价值研究[J]. 中国实用医药,2021,16(15):74-76
分析[J]. 中国胸心血管外科临床杂志,2019,26(8): [收稿日期] 2021-08-23
789-794 (本文编辑:蒋 莉)
(上接第1363页)
及其临床意义[J]. 南京医科大学学报(自然科学版), proliferation and growth of colorectal cancer cells through
2018,38(4):497-499 transcriptionally inhibiting HMGCS1⁃mediated cholester⁃
[11] QI Y J,CHAO W X,CHIU J F. An overview of esopha⁃ ol biosynthesis[J]. Cell Biosci,2020,10:76
geal squamous cell carcinoma proteomics[J]. J Pro⁃
[16] ZHANG J,JIANG M,QIAN L,et al. The STAT3⁃miR⁃223
teomics,2012,75(11):3129-3137
⁃TGFBR3/HMGCS1 axis modulates the progression of cer⁃
[12] TIAN S,SIU F M,LOK C,et al. Anticancer auranofin en⁃
vical carcinoma[J]. Mol Oncol,2020,14(9):2313-2331
gages 3⁃hydroxy⁃3⁃methylglutaryl⁃coenzyme A reductase
[17] LI H,CHU J,JIA J,et al. LncRNA LOXL1⁃AS1 promotes
(HMGCR)as a target[J]. Metallomics,2019,11(11):
esophageal squamous cell carcinoma progression by tar⁃
1925-1936
geting DESC1[J]. J Cancer,2021,12(2):530-538
[13] MA S,SUN W,GAO L,et al. Therapeutic targets of hyper⁃
[18] MEERZAMAN D M,YAN C,CHEN Q R,et al. Genome⁃
cholesterolemia:HMGCR and LDLR[J]. Diabetes Metab
wide transcriptional sequencing identifies novel muta⁃
Syndr Obes,2019,12:1543-1553
tions in metabolic genes in human hepatocellular carcino⁃
[14] WANG I H,HUANG T T,CHEN J L,et al. Mevalonate
pathway enzyme HMGCS1 contributes to gastric cancer ma[J]. Cancer Genomics Proteomics,2014,11(1):1-12
progression[J]. Cancers(Basel),2020,12(5):E1088 [收稿日期] 2022-01-06
[15] YAO W,JIAO Y,ZHOU Y,et al. KLF13 suppresses the (责任编辑:蒋 莉)